James J. Harding

Associate Professor of Medicine
Medicine

James J. Harding serves as Associate Professor at Cornell University.

583 publications
18,101 citations
54 h-index
Medicine
Recent Papers (9)
2026-07-01 · Journal of Hepatology · Surgery
Systemic therapy of biliary tract cancer: The road to personalised strategies
James J. HardingAssociate Professor of Medicine · Medicine
2026-05-27 · Journal of Clinical Oncology · Surgery
Association of genomic and clinical factors with outcomes with front-line chemoimmunotherapy in patients with advanced biliary tract cancer.
James J. HardingAssociate Professor of Medicine · Medicine
2026-05-27 · Journal of Clinical Oncology · Surgery
Tracking genomic evolution in ERBB2 -altered biliary tract cancer through longitudinal tumor profiling.
James J. HardingAssociate Professor of Medicine · Medicine
2026-04-16 · Cancer Research Communications · Oncology
BI 905711, a TRAILR2/CDH17 Bispecific Antibody, Alone or with Chemotherapy for Patients with Advanced Gastrointestinal Cancers: Phase I Study Findings
James J. HardingAssociate Professor of Medicine · Medicine
2026-03-25 · Nature Medicine · Oncology
Pembrolizumab and olaparib in homologous-recombination-deficient metastatic pancreatic cancer: the phase 2 POLAR trial
James J. HardingAssociate Professor of Medicine · Medicine
2026-02-19 · Clinical Cancer Research · Surgery
Shaping the Future of HER2-Directed Therapy in Biliary Tract Cancer
James J. HardingAssociate Professor of Medicine · Medicine
2026-01-10 · Journal of Clinical Oncology · Surgery
Landmark analysis of overall survival (OS) by objective response in patients (pts) with previously treated, advanced HER2-positive biliary tract cancer (BTC): Post hoc analysis of the HERIZON-BTC-01 trial.
James J. HardingAssociate Professor of Medicine · Medicine
2025-11-20 · JAMA Oncology
Zanidatamab in HER2-Positive Metastatic Biliary Tract Cancer
James J. HardingAssociate Professor of Medicine · Medicine
2025-11-17 · Annals of Surgical Oncology
ASO Visual Abstract: Outcomes of First-versus Second-Line Hepatic Artery Infusion Chemotherapy in Unresectable Intrahepatic Cholangiocarcinoma
James J. HardingAssociate Professor of Medicine · Medicine